A clinical guide to endodontics - Update part 2

British Dental Journal

Volumn 206, Issue 3, 2009, Pages 133-139

  Carrotte, P V ^a   Waterhouse, P J ^b  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; DENTAL CARE; DENTISTRY; DENTITION; ENDODONTICS; HUMAN; INSTRUMENTATION; METHODOLOGY; TOOTH PULP DISEASE;

ADOLESCENT; CHILD; DENTAL CARE FOR CHILDREN; DENTAL PULP DISEASES; DENTITION, PRIMARY; ENDODONTICS; HUMANS; PEDIATRIC DENTISTRY; ROOT CANAL THERAPY;

EID: 60449093140     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/sj.bdj.2009.56     Document Type: Article

References (40)

1. Iwamoto C E, Adachi E, Pameijer C H, Barnes D, Romberg E E, Jefferies S. Clinical and histological evaluation of white ProRoot MTA in direct pulp capping. Am J Dent 2006; 19: 85-90.
2. Patel R, Cohenca N. Maturogenesis of a cariously exposed immature permanent tooth using MTA for direct pulp capping: a case report. Dent Traumatol 2006; 22: 328-333.
3. Bjorndal L, Kidd E A M. The treatment of deep dentine caries lesions. Dent Update 2005; 32: 402-404, 407-410, 413.
4. Ricketts D N J, Kidd E A M, Innes N, Clarkson J. Complete or ultraconservative removal of decayed tissue in unfilled teeth. Cochrane Database Syst Rev 2006; (3): CD003808. DOI: 10.1002/14561858. CD003808.pub2.
5. Pinto A S, de Araujo F B, Franzon R et al. Clinical and microbiological effect of calcium hydroxide protection in indirect pulp capping in primary teeth. Am J Dent 2006; 19: 382-386.
6. Marchi J J, de Araujo F B, Froner A M, Straffon L H, Nor J E. Indirect pulp capping in the primary dentition: a four year follow-up study. J Clin Pediatr Dent 2006; 31: 68-71.
7. Srinivasan V, Patchett C L, Waterhouse P J. Is there life after Buckley's formocresol? Part I - a narrative review of alternative interventions and materials. Int J Paediatr Dent 2006; 16: 117-127.
8. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomised controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. Int Endod J 2007; 40: 261-267.
9. Caicedo R, Abbott P V, Alongi D J, Alarcon M Y. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of deciduous teeth. Aust Dent J 2006; 51: 297-305.
10. Witherspoon D E, Small J C, Harris G Z. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment. J Am Dent Assoc 2006; 137: 610-618.
11. Holan G, Eidelman E, Fuks A B. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent 2005; 27: 129-136.
12. Agamy H A, Bakry N S, Mounir M M, Avery D R. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized teeth. Pediatr Dent 2004; 26: 302-309.
13. Waterhouse P J. Formocresol and alternative primary molar pulpotomy medicaments. A review. Endod Dent Traumatol 1995; 11: 157-162.
14. Farooq N S, Coll J A, Kuwabara A, Shelton P. Success rates of formocresol pulpotomy and indirect pulp treatment in the treatment of deep dentinal caries in primary teeth. Pediatr Dent 2000; 22: 278-286.
15. Nunn J H, Smeaton I, Gilroy J. The development of formocresol as a medicament for primary molar pulpotomy procedures. ASDC J Dent Child 1996; 63: 51-53.
16. Rodd H D, Waterhouse P J, Fuks A B, Fayle S A, Moffat M A. UK national guidelines in paediatric dentistry. Pulp therapy for primary molars. Int J Paediatr Dent 2006; 16(Suppl 1): 15-23.
17. Rodd H D, Boissonade F M. Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp. Int J Paediatr Dent 2006; 16: 2-9.
18. Hunter M L, Hunter B. Vital pulpotomy in the primary dentition: attitudes and practices of specialists in paediatric dentistry practising in the United Kingdom. Int J Paediatr Dent 2003; 13: 246-250.
19. International Agency for Research on Cancer. IARC classifies formaldehyde as carcinogenic to humans. Lyon: IARC, 2004. Press release No. 153.
20. HSE ACTS Working Group on Action to Control Chemicals. WATCH committee paper 2005/6. The carcinogenicity of formaldehyde. London: HSE, 2005. http://www.hse.gov.uk/aboutus/meetings/iacs/acts/watch/130105/p6.pdf (accessed 15 January 2009).
21. Patchett C L, Srinivasan V, Waterhouse P J. Is there life after Buckley's formocresol? Part II - development of a protocol for the management of extensive caries in the primary molar. Int J Paediatr Dent 2006; 16: 199-206.
22. Aktoren O, Gencay K. A two year clinical-radiographic follow-up of the pulpotomies in primary molars. J Dent Res 2000; 79: 543 (Abstract 3193).
23. Ibricevic H, Al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. Pediatr Dent 2000; 24: 269-272.
24. Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent 2005; 6: 133-138.
25. Fei A, Udin R, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatr Dent 1991; 13: 327-332.
26. Fuks A B, Eidelman E, Cleaton-Jones P, Michaeli Y. Pulpal response to ferric sulfate, diluted formocresol and IRM in pulpotomized primary baboon teeth. ASDC J Dent Child 1997; 64: 254-259.
27. Pappagiannoulis L. Clinical studies on ferric sulphate as a pulpotomy medicament in primary teeth. Eur J Paediatr Dent 2002; 3: 126-132.
28. Huth K C, Paschos E, Hajek-Al-Khatar N et al. Effectiveness of 4 pulpotomy techniques - randomized controlled trial. J Dent Res 2005; 84: 1144-1148.
29. Cuisia Z E, Musselman R, Schneider P, Dummett C. A study of mineral trioxide aggregate pulpotomies in primary molars. Pediatr Dent 2001; 23: 168 (Abstract).
30. Agamy H A, Bakry N S, Mounir M M F, Avery D R. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004; 26: 302-309.
31. Jabbarifar S E, Khademi A A, Ghasemi D. Success rate of formocresol pulpotomy versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci 2004; 6: 55-58.
32. Farsi N, Alamoudi N, Balto K, Mushayt A. Success of mineral trioxide aggregate in pulpotomized primary molars. J Clin Pediatr Dent 2005; 29: 307-311.
33. Holan G, Eidelman E, Fuks A B. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent 2005; 27: 129-136.
34. Naik S, Hegde A M. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. J Indian Soc Pedod Prev Dent 2005; 23: 13-17.
35. Peng L, Ye L, Guo X et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. Int Endod J 2007; 40: 751-757.
36. Gould A, Johnstone S, Smith P. Pulp therapy techniques for the deciduous dentition. London: King's College London, 1999. Compact Disc.
37. Barr E S, Flaitz C M, Hicks M J. A retrospective radiographic evaluation of primary molar pulpectomies. Pediatr Dent 1991; 13: 4-9.
38. Casas M J, Kenny D J, Johnston D H, Judd P J. Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent 2004; 26: 44-48.
39. Mortazavi M, Mesbahi M. Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. Int J Paediatr Dent 2004; 14: 417-424.
40. Deery C, Hosey M-T, Waterhouse P J. Pulp therapy in the primary dentition. In Paediatric cariology. London: Quintessence Publishing Co. Ltd, 2004.